Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosis. Issue 10 (July 2014)
- Record Type:
- Journal Article
- Title:
- Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosis. Issue 10 (July 2014)
- Main Title:
- Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosis
- Authors:
- Morgan, V. A.
McGrath, J. J.
Jablensky, A.
Badcock, J. C.
Waterreus, A.
Bush, R.
Carr, V.
Castle, D.
Cohen, M.
Galletly, C.
Harvey, C.
Hocking, B.
McGorry, P.
Neil, A. L.
Saw, S.
Shah, S.
Stain, H. J.
Mackinnon, A. - Abstract:
- <abstract abstract-type="normal"> <title> <x content-type="archive" xml:space="preserve">Abstract</x> </title> <sec id="sec_a1"> <title>Background</title> <p>There are insufficient data from nationwide surveys on the prevalence of specific psychotic disorders and associated co-morbidities.</p> </sec> <sec id="sec_a2" sec-type="methods"> <title>Method</title> <p>The 2010 Australian national psychosis survey used a two-phase design to draw a representative sample of adults aged 18–64 years with psychotic disorders in contact with public treatment services from an estimated resident population of 1 464 923 adults. This paper is based on data from 1642 participants with an International Classification of Diseases (ICD)-10 psychotic disorder. Its aim is to present estimates of treated prevalence and lifetime morbid risk of psychosis, and to describe the cognitive, physical health and substance use profiles of participants.</p> </sec> <sec id="sec_a3" sec-type="results"> <title>Results</title> <p>The 1-month treated prevalence of psychotic disorders was 3.10 cases per 1000 population aged 18–64 years, not accounting for people solely accessing primary care services; lifetime morbid risk was 3.45 per 1000. Mean premorbid intelligence quotient was approximately 0.5 s<sc>.d.</sc>s below the population mean; current cognitive ability (measured with a digit symbol coding task) was 1.6 s<sc>.d</sc>.s below the population mean. For both cognitive tests, higher scores were significantly<abstract abstract-type="normal"> <title> <x content-type="archive" xml:space="preserve">Abstract</x> </title> <sec id="sec_a1"> <title>Background</title> <p>There are insufficient data from nationwide surveys on the prevalence of specific psychotic disorders and associated co-morbidities.</p> </sec> <sec id="sec_a2" sec-type="methods"> <title>Method</title> <p>The 2010 Australian national psychosis survey used a two-phase design to draw a representative sample of adults aged 18–64 years with psychotic disorders in contact with public treatment services from an estimated resident population of 1 464 923 adults. This paper is based on data from 1642 participants with an International Classification of Diseases (ICD)-10 psychotic disorder. Its aim is to present estimates of treated prevalence and lifetime morbid risk of psychosis, and to describe the cognitive, physical health and substance use profiles of participants.</p> </sec> <sec id="sec_a3" sec-type="results"> <title>Results</title> <p>The 1-month treated prevalence of psychotic disorders was 3.10 cases per 1000 population aged 18–64 years, not accounting for people solely accessing primary care services; lifetime morbid risk was 3.45 per 1000. Mean premorbid intelligence quotient was approximately 0.5 s<sc>.d.</sc>s below the population mean; current cognitive ability (measured with a digit symbol coding task) was 1.6 s<sc>.d</sc>.s below the population mean. For both cognitive tests, higher scores were significantly associated with better independent functioning. The prevalence of the metabolic syndrome was high, affecting 60.8% of participants, and pervasive across diagnostic groups. Of the participants, two-thirds (65.9%) were current smokers, 47.4% were obese and 32.4% were sedentary. Of the participants, half (49.8%) had a lifetime history of alcohol abuse/dependence and 50.8% lifetime cannabis abuse/dependence.</p> </sec> <sec id="sec_a4" sec-type="conclusion"> <title>Conclusions</title> <p>Our findings highlight the need for comprehensive, integrative models of recovery to maximize the potential for good health and quality of life for people with psychotic illness.</p> </sec> </abstract> … (more)
- Is Part Of:
- Psychological medicine. Volume 44:Issue 10(2014)
- Journal:
- Psychological medicine
- Issue:
- Volume 44:Issue 10(2014)
- Issue Display:
- Volume 44, Issue 10 (2014)
- Year:
- 2014
- Volume:
- 44
- Issue:
- 10
- Issue Sort Value:
- 2014-0044-0010-0000
- Page Start:
- 2163
- Page End:
- 2176
- Publication Date:
- 2014-07
- Subjects:
- Psychiatry -- Periodicals
Medicine and psychology -- Periodicals
Clinical psychology -- Periodicals
616.89 - Journal URLs:
- http://journals.cambridge.org/action/displayJournal?jid=PSM ↗
- DOI:
- 10.1017/S0033291713002973 ↗
- Languages:
- English
- ISSNs:
- 0033-2917
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 3317.xml